FDA Approved: HALOPERIDOL DECANOATE — Original Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved BluePoint Laboratories' haloperidol decanoate long-acting injectable under an original application for the treatment of schizophrenia. This mar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• HALOPERIDOL DECANOATE (Haloperidol decanoate)

Snippet

ORIG AP for HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)